SG11201704430SA - Preventive and/or therapeutic agent of immune disease - Google Patents

Preventive and/or therapeutic agent of immune disease

Info

Publication number
SG11201704430SA
SG11201704430SA SG11201704430SA SG11201704430SA SG11201704430SA SG 11201704430S A SG11201704430S A SG 11201704430SA SG 11201704430S A SG11201704430S A SG 11201704430SA SG 11201704430S A SG11201704430S A SG 11201704430SA SG 11201704430S A SG11201704430S A SG 11201704430SA
Authority
SG
Singapore
Prior art keywords
preventive
therapeutic agent
immune disease
immune
disease
Prior art date
Application number
SG11201704430SA
Inventor
Fumihito Hosoi
Yoshinori Nakachi
Daisuke Kajiwara
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of SG11201704430SA publication Critical patent/SG11201704430SA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
SG11201704430SA 2015-01-30 2016-01-29 Preventive and/or therapeutic agent of immune disease SG11201704430SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015017386 2015-01-30
PCT/JP2016/052732 WO2016121953A1 (en) 2015-01-30 2016-01-29 Prophylactic and/or therapeutic agent for immune diseases

Publications (1)

Publication Number Publication Date
SG11201704430SA true SG11201704430SA (en) 2017-08-30

Family

ID=56543555

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201704430SA SG11201704430SA (en) 2015-01-30 2016-01-29 Preventive and/or therapeutic agent of immune disease

Country Status (21)

Country Link
US (1) US9782412B2 (en)
EP (1) EP3120852B1 (en)
JP (1) JP6093485B2 (en)
KR (1) KR101858421B1 (en)
CN (2) CN113768935A (en)
AU (1) AU2016213030B2 (en)
BR (1) BR112017016278B1 (en)
CA (1) CA2975372C (en)
DK (1) DK3120852T3 (en)
ES (1) ES2734364T3 (en)
HU (1) HUE045532T2 (en)
MX (1) MX2017009863A (en)
MY (1) MY197518A (en)
PH (1) PH12017501336A1 (en)
PL (1) PL3120852T3 (en)
PT (1) PT3120852T (en)
RU (1) RU2705154C2 (en)
SG (1) SG11201704430SA (en)
TR (1) TR201910158T4 (en)
TW (1) TWI638817B (en)
WO (1) WO2016121953A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3115365T3 (en) 2015-01-30 2018-05-28 Taiho Pharmaceutical Co Ltd HIS UNKNOWN SALT OF CONDENSED PYRIMIDIDE COMPOUND AND CRYSTALS THEREOF
EP4079306A4 (en) * 2019-12-19 2024-01-10 Taiho Pharmaceutical Co Ltd Therapeutic agent containing fused pyrimidine compound as active ingredient
CN112209894B (en) * 2020-10-23 2023-06-06 贵州医科大学 5-aryl substituted 2-aminobenzoxazole derivative, preparation method and application thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070135387A1 (en) 2005-12-08 2007-06-14 Michaelides Michael R Inhibitors of protein kinases
ATE522216T1 (en) * 2006-09-13 2011-09-15 Takeda Pharmaceutical USE OF 2-6-(3-AMINE-PIPERIDINE-1-YL)-3-METHYL-2,4-DIOXO-3,4-DIHYDRO-2H-PYRIMIDINE-1-YLMETHYL-4-FLUORO-BENZONITRILE FOR THE TREATMENT OF DIABETES, CANCER, AUTOIMMUNE DISEASES AND HIV INFECTIONS
WO2008054827A2 (en) * 2006-11-03 2008-05-08 Pharmacyclics, Inc. Bruton's tyrosine kinase activity probe and method of using
JP2009235057A (en) * 2007-10-31 2009-10-15 Santen Pharmaceut Co Ltd New indole derivative having anti-angiogenesis activity
TWI546290B (en) 2008-06-27 2016-08-21 賽基艾維洛米斯研究股份有限公司 Heteroaryl compounds and uses thereof
US8338439B2 (en) 2008-06-27 2012-12-25 Celgene Avilomics Research, Inc. 2,4-disubstituted pyrimidines useful as kinase inhibitors
BR112014000653A2 (en) * 2011-07-13 2017-02-14 Pharmacyclics Inc bruton tyrosine kinase inhibitors
MX351513B (en) * 2012-01-19 2017-10-17 Taiho Pharmaceutical Co Ltd 3,5-disubstituted alkynylbenzene compound and salt thereof.
EP2890691B1 (en) * 2012-08-31 2018-04-25 Principia Biopharma Inc. Benzimidazole derivatives as itk inhibitors
CN105452257B (en) 2013-08-12 2017-09-05 大鹏药品工业株式会社 Novel fused pyrimidine compound or its salt

Also Published As

Publication number Publication date
EP3120852A4 (en) 2017-05-24
PT3120852T (en) 2019-07-16
US20170042900A1 (en) 2017-02-16
MX2017009863A (en) 2017-11-15
HUE045532T2 (en) 2020-01-28
EP3120852A1 (en) 2017-01-25
BR112017016278A2 (en) 2018-03-27
AU2016213030B2 (en) 2019-01-31
JPWO2016121953A1 (en) 2017-04-27
BR112017016278B1 (en) 2022-05-10
TW201632526A (en) 2016-09-16
CN107206001B (en) 2021-09-28
CN107206001A (en) 2017-09-26
EP3120852B1 (en) 2019-05-01
KR20170083640A (en) 2017-07-18
DK3120852T3 (en) 2019-07-29
TWI638817B (en) 2018-10-21
ES2734364T3 (en) 2019-12-05
JP6093485B2 (en) 2017-03-08
RU2705154C2 (en) 2019-11-05
WO2016121953A1 (en) 2016-08-04
TR201910158T4 (en) 2019-07-22
CN113768935A (en) 2021-12-10
CA2975372C (en) 2020-01-14
US9782412B2 (en) 2017-10-10
KR101858421B1 (en) 2018-05-15
CA2975372A1 (en) 2016-08-04
MY197518A (en) 2023-06-19
AU2016213030A1 (en) 2017-06-22
RU2017127126A (en) 2019-03-01
PL3120852T3 (en) 2019-09-30
RU2017127126A3 (en) 2019-03-01
PH12017501336A1 (en) 2017-12-11

Similar Documents

Publication Publication Date Title
IL277648A (en) Therapeutic microbiota for the treatment and/or prevention of food allergy
HK1252873A1 (en) Vaccines for treatment and prevention of cancer
IL258854A (en) Compositions comprising cannabidiol and second therapeutic agents for the treatment of cancer
ZA201902090B (en) Combination treatments comprising administration of imidazopyrazinones
SG10201402819WA (en) Composition for prevention and treatment of joint pain and the method of preparation thereof
IL266047A (en) Methods and compositions for the treatment of fabry disease
IL247368A0 (en) Diagnostic and therapeutic uses of exosomes
IL266486A (en) Pharmaceutical compositions and methods for the treatment of cancer
HK1246689A1 (en) Fixed dose combination of bromonidine and timolol
IL259710A (en) Compositions and methods of treatment for mvid and related diseases
PT3081228T (en) Irisin for care and prevention of osteoporosis
GB201504387D0 (en) Materials and methods for the treatment of vascular disease
HK1258056A1 (en) Therapeutic compounds and methods of use thereof
SG11201704430SA (en) Preventive and/or therapeutic agent of immune disease
ZA201906964B (en) Prevention and/or treatment of inflammatory skin disease
GB201522329D0 (en) Use of adjuvants for the prevention and/or treatment of autoimmune diseases
PL3137097T3 (en) Treatment and prevention of alzheimer's disease (ad)
HK1246271A1 (en) Method for the synthesis of hydroxy-triglycerides and uses thereof for the prevention and treatment of diseases
EP3377062C0 (en) Aminonaphthoquinone compounds for treatment and/or prevention of fibrosis diseases
LT3137093T (en) Treatment and prevention of alzheimer`s disease (ad)
PT3137094T (en) Treatment and prevention of alzheimer's disease (ad)
IL257689A (en) Pharmaceutical compositions and methods for the treatment of hypoxia-related diseases
IL259383A (en) Compound for use in the prevention and treatment of neurodegenerative diseases
GB201621398D0 (en) Treatment of emt-associated disease
GB201522828D0 (en) Prevention and treatment of glaucoma